Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in sepsis therapy.

Thomas Glück1, Steven M Opal

  • 1Klinik und Poliklinik für Innere Medizin I, Universitätsklinikum Regensburg, Regensburg, Germany.

Drugs
|April 3, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[A circuitous route to the diagnosis of a very rare disease].

Innere Medizin (Heidelberg, Germany)·2025
Same author

Role and benefits of infectious diseases specialists in the COVID-19 pandemic: Multilevel analysis of care provision in German hospitals using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS) cohort.

Infection·2024
Same author

Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects.

Infection·2022
Same author

Omicron's binding to sotrovimab, casirivimab, imdevimab, CR3022, and sera from previously infected or vaccinated individuals.

iScience·2022
Same author

Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel.

Infection·2021
Same author

Evaluation of a Broad Panel of SARS-CoV-2 Serological Tests for Diagnostic Use.

Journal of clinical medicine·2021

Recent advances in understanding sepsis pathogenesis have led to new, effective therapies. These treatments, including supportive care and novel drugs, significantly improve survival rates for severe sepsis patients.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pathophysiology

Background:

  • Sepsis pathogenesis understanding has lagged, hindering therapeutic development.
  • Recent breakthroughs in basic science have paved the way for novel sepsis treatments.
  • Severe sepsis remains a complex syndrome with significant patient mortality.

Purpose of the Study:

  • To review recent advancements in sepsis understanding and treatment.
  • To highlight new therapeutic strategies improving outcomes in severe sepsis.
  • To discuss the evolving landscape of sepsis management.

Main Methods:

  • Review of recent scientific literature on sepsis pathogenesis and therapy.
  • Analysis of new treatment modalities including supportive care, endocrine management, and novel agents.

Related Experiment Videos

  • Synthesis of findings on improved patient outcomes in severe sepsis.

    • Main Results:

    • New insights into sepsis pathogenesis have yielded successful therapies.
    • Effective supportive measures include early goal-oriented therapy, endocrine management (hydrocortisone, glucose control), and optimized ventilation.
    • Human recombinant activated protein C (drotrecogin alfa) reduces mortality by improving coagulation and endothelial function.

    Conclusions:

    • Advances in understanding sepsis pathophysiology have led to improved patient outcomes.
    • Individualized supportive care and addressing the underlying cause are crucial.
    • Further clinical investigations are needed to integrate new, potentially expensive therapies into standard sepsis care.